<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pediculosis capitis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pediculosis capitis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pediculosis capitis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Adam O Goldstein, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Beth G Goldstein, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Moise L Levy, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ted Rosen, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Abena O Ofori, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 12, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2010251585"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Pediculosis capitis is a common condition caused by infestation of the hair and scalp by <em>Pediculus humanus capitis</em> (the head louse), one of three distinct varieties of lice specifically parasitic for humans  (<a class="graphic graphic_figure graphicRef52420" href="/z/d/graphic/52420.html" rel="external">figure 1</a>) [<a href="#rid1">1</a>]. The clinical manifestations, diagnosis, and treatment of pediculosis capitis will be reviewed here. Other forms of louse infestation, including pediculosis corporis and pediculosis pubis, are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4036.html" rel="external">"Pediculosis corporis"</a> and  <a class="medical medical_review" href="/z/d/html/4037.html" rel="external">"Pediculosis pubis and pediculosis ciliaris"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Pediculosis capitis occurs worldwide and in individuals of all socioeconomic backgrounds [<a href="#rid2">2,3</a>]. Children are affected most frequently.</p><p class="headingAnchor" id="H3"><span class="h1">LIFE CYCLE</span><span class="headingEndMark"> — </span>The life span of the female louse is about one month, during which she lays 7 to 10 eggs per day, cementing them firmly to the base of a host hair. The eggs, commonly called "nits," are oval capsules that hatch in eight days, releasing nymphs that require another eight days to mature  (<a class="graphic graphic_picture graphicRef74790 graphicRef56619" href="/z/d/graphic/74790.html" rel="external">picture 1A-B</a>). After hatching, egg cases become white and more visible.</p><p>Adult head lice are gray-white, 2 to 3 mm in length  (<a class="graphic graphic_picture graphicRef80788 graphicRef104641" href="/z/d/graphic/80788.html" rel="external">picture 2A-B</a>), and equipped with mouth parts adapted to sucking blood and legs adapted to grasping hairs. Adults feed both on the scalp and adjacent areas of the face and neck. Adult lice can survive up to 55 hours without a host [<a href="#rid4">4</a>] but probably dehydrate and become nonviable long before their death [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H1257130"><span class="h1">TRANSMISSION</span><span class="headingEndMark"> — </span>Direct contact with the head of an infested person is the primary mode of transmission of pediculosis capitis [<a href="#rid5">5,6</a>]. Lice do not jump, fly, or use pets as vectors.</p><p>The contribution of inanimate objects to the spread of pediculosis capitis is controversial [<a href="#rid7">7,8</a>]. While a study performed in an experimental setting suggested that use of hair dryers, combs, or towels could lead to louse transmission [<a href="#rid9">9</a>], other studies investigating the prevalence of lice on hats, bedding, and floors after exposure to an infested individual have not supported these routes as important modes of transmission [<a href="#rid10">10-12</a>].</p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Pruritus occurs as an allergic reaction to lice saliva injected during feeding. In a patient without prior infestation, the onset of itching may be delayed until sensitization occurs after four to six weeks [<a href="#rid13">13</a>].</p><p>In addition to lice and nits, excoriations may be visible on the scalp, neck, and postauricular skin  (<a class="graphic graphic_picture graphicRef105400" href="/z/d/graphic/105400.html" rel="external">picture 3</a>). Infrequently, secondary staphylococcal infection occurs with associated cervical or nuchal lymph node enlargement.</p><p class="headingAnchor" id="H5"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Pediculosis capitis should be suspected in patients with scalp pruritus, particularly in children. Persistent pyoderma around the neck or ears should also stimulate an evaluation for pediculosis capitis.</p><p>The diagnosis is confirmed by the visualization of live lice  (<a class="graphic graphic_picture graphicRef80788 graphicRef104643" href="/z/d/graphic/80788.html" rel="external">picture 2A, 2C</a>). Systematically combing wet or dry hair with a fine-toothed nit comb (teeth of comb 0.2 mm apart) better detects active louse infestation than visual inspection of the hair and scalp alone [<a href="#rid14">14,15</a>]. In a comparison study, a wet-combing technique resulted in a sensitivity of 91 percent for the detection of live lice, compared with a sensitivity of 29 percent observed with visual inspection [<a href="#rid14">14</a>]. It has been suggested that wet combing is the most sensitive diagnostic technique; however, wet combing and dry combing have not been compared directly in clinical studies [<a href="#rid14">14</a>].</p><p>To perform wet combing, a lubricant such as a hair conditioner is applied to the hair prior to the following steps, which are also used for the dry-combing method [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The hair is brushed or combed to remove tangles.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A fine-toothed comb is inserted near the crown until it gently touches the scalp, after which it is drawn firmly down and examined for lice after each stroke.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The entire head is combed systematically at least twice.</p><p></p><p>Nits are often more easily found than nymphs and adult lice, which are elusive  (<a class="graphic graphic_picture graphicRef65846 graphicRef74790 graphicRef104642" href="/z/d/graphic/65846.html" rel="external">picture 1A, 1C-D</a>). Unlike seborrheic scales, hair casts, and hair spray residue, nits are cemented securely to the hair shaft and are difficult to dislodge. Light microscopy or dermoscopy can be used to confirm a nit  (<a class="graphic graphic_picture graphicRef56619 graphicRef114997 graphicRef115133" href="/z/d/graphic/56619.html" rel="external">picture 1B, 1E-F</a>) [<a href="#rid16">16</a>]. Examination with a Wood's lamp causes nits to fluoresce a pale blue and can facilitate harvest for microscopic examination. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>However, the finding of nits without lice does not confirm active infestation. Nits can persist after successful therapy [<a href="#rid2">2</a>]. Active infestation is suggested by the finding of many nits within one-quarter inch (6.5 mm) of the scalp; nits further from the scalp are almost always nonviable [<a href="#rid6">6</a>]. However, even this criterion results in overdiagnosis. As an example, in a study in which 1729 elementary school children were screened for lice, 28 (1.6 percent) had active lice while 63 (3.6 percent) had nits without lice, of whom 50 completed follow-up [<a href="#rid17">17</a>]. During two weeks of follow-up, only 9 of the 50 children who initially had nits alone (18 percent) converted to an active infestation. Having ≥5 nits within one-quarter inch of the scalp was associated with a higher conversion rate than fewer nits (32 versus 7 percent).</p><p>The diagnosis of lice is traumatic for some patients and parents/caregivers and can lead to concern for continued infestation even after cure is complete. Tact, reassurance, and empathy on the part of the clinician are helpful.</p><p class="headingAnchor" id="H1023501"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Nits should be distinguished from hair casts, white piedra, and black piedra:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hair casts </strong>– Hair casts (also known as pseudonits) are white to yellow, 2 to 7 mm, keratinous, tubular sheaths that encircle hair shafts  (<a class="graphic graphic_picture graphicRef101623" href="/z/d/graphic/101623.html" rel="external">picture 4</a>). Hair casts may be idiopathic (primary hair casts) or may occur in association with a scalp condition such as seborrheic dermatitis or psoriasis [<a href="#rid18">18,19</a>]. Unlike nits, hair casts slide easily along the hair shaft.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Piedra </strong>– Nits also should be distinguished from white and black piedra, fungal infections most commonly found in tropical areas that present with white to beige (white piedra) or brown to black (black piedra) concretions on hair shafts  (<a class="graphic graphic_picture graphicRef69898 graphicRef89954 graphicRef89956" href="/z/d/graphic/69898.html" rel="external">picture 5A-C</a>) [<a href="#rid20">20</a>]. The concretions may reach up to a few millimeters in length. White piedra is caused by <em>Trichosporon</em> species, and black piedra is caused by <em>Piedraia hortae</em>. The nodules of white piedra tend to be soft and loosely adhered to the hair shaft, whereas black piedra nodules are hard and firmly attached. White piedra affects the face, axillae, and genitals more often than scalp hair. In contrast, black piedra is most likely to occur on scalp and facial hair. (See  <a class="medical medical_review" href="/z/d/html/2456.html" rel="external">"Infections due to Trichosporon species and Blastoschizomyces capitatus (Saprochaete capitata)"</a>.)</p><p></p><p>When the diagnosis is uncertain, microscopic examination of the hair can distinguish nits from piedra and hair casts  (<a class="graphic graphic_picture graphicRef56619" href="/z/d/graphic/56619.html" rel="external">picture 1B</a>). Moreover, in piedra, a potassium hydroxide (KOH) preparation of an involved area will reveal fungal elements. (See  <a class="medical medical_review" href="/z/d/html/5562.html" rel="external">"Office-based dermatologic diagnostic procedures", section on 'Potassium hydroxide preparation'</a>.)</p><p>In addition to pediculosis capitis, scalp pruritus may occur in multiple other scalp disorders, such as seborrheic dermatitis and atopic dermatitis. The finding of nits or live lice distinguishes pediculosis capitis. (See  <a class="medical medical_review" href="/z/d/html/16261.html" rel="external">"Cradle cap and seborrheic dermatitis in infants"</a> and  <a class="medical medical_review" href="/z/d/html/13669.html" rel="external">"Seborrheic dermatitis in adolescents and adults"</a>.)</p><p class="headingAnchor" id="H6"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Treatment of pediculosis capitis is recommended. Topical pediculicides are the most common initial treatments. Manual removal of lice (wet combing) is sometimes used as an alternative to topical pediculicide therapy. Oral therapy is occasionally required for refractory infestations. </p><p>Regardless of the treatment selected, the presence of living lice should be confirmed prior to treatment [<a href="#rid13">13</a>]. Patients with nits but no detectable nymphs or adult lice likely do not have active infection if nits are only found more than 6.5 mm from the scalp. These patients do not require treatment.</p><p>Many patients with nits less than 6.5 mm from the scalp and no detectable nymphs or adult lice also do not have active infestation [<a href="#rid17">17</a>]. Clinician approaches to these patients vary. Whereas some clinicians elect to treat based upon the possibility of missing live lice during the examination, others follow patients clinically for signs of active infestation to avoid unnecessary treatment. (See <a class="local">'Diagnosis'</a> above.)</p><p class="headingAnchor" id="H88337"><span class="h2">First-line treatment</span><span class="headingEndMark"> — </span>Multiple topical pediculicides are accepted first-line treatments for pediculosis capitis. Wet combing is an alternative intervention that is primarily used for very young infants and patients who prefer to avoid pediculicides. (See <a class="local">'Wet combing'</a> below.)</p><p class="headingAnchor" id="H1255275"><span class="h3">Topical pediculicides</span><span class="headingEndMark"> — </span>Examples of effective topical pediculicides include  (<a class="graphic graphic_table graphicRef105474" href="/z/d/graphic/105474.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Pyrethroids (pyrethrins, <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a>)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">Malathion</a></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="16101" href="/z/d/drug information/16101.html" rel="external">Spinosad</a></p><p class="bulletIndent1"><span class="glyph">●</span>Topical <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a></p><p></p><p>Topical pediculicides should be applied according to the package instructions. Basic principles for treatment include:</p><p class="bulletIndent1"><span class="glyph">●</span>Topical pediculicides should be rinsed off with <strong>water</strong> after the recommended time. Rinsing of topical pediculicides should be performed over a sink rather than in a shower or bath to limit skin exposure [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rinsing with warm water is preferred over hot water to minimize vasodilation and systemic absorption [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hair should not be washed with shampoo for 24 to 48 hours after treatment [<a href="#rid13">13</a>].</p><p></p><p>Topical <a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">lindane</a> is not recommended as a first-line treatment for pediculosis capitis because of safety concerns. (See <a class="local">'Lindane'</a> below.)</p><p class="headingAnchor" id="H1255281"><span class="h4">Selection</span><span class="headingEndMark"> — </span>Pediculicide choice should be made based on several factors, including agent-specific side effects, patient age, treatment cost, and resistance patterns to topical agents [<a href="#rid21">21-29</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Resistance </strong>– Resistance, particularly to pyrethroids and <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a>, is a growing concern, and geographical variability exists in the prevalence of pediculicide resistance. A mutation in the louse kdr allele that results in decreased sensitivity of neuronal voltage-gated sodium channels has been proposed as the primary mechanism for pyrethroid resistance [<a href="#rid30">30</a>]. Rates of kdr resistance appear to be high in the United States based upon a study in which over 14,000 lice were collected from 138 collection sites in 48 states and analyzed with quantitative sequencing for kdr mutations [<a href="#rid31">31</a>]. Of the 138 collection sites, 132 (96 percent) had a mean percent resistance allele frequency of 100 percent. However, the clinical relevance of kdr mutations is brought into question by a study that found a poor correlation between mutations in kdr and treatment failure [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1">Resistance to <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a> occurs via increased production of enzymes that metabolize malathion and decreased sensitivity of neuronal acetylcholinesterase to the drug [<a href="#rid21">21</a>]. Other pathways for resistance also may be involved. Resistance to malathion appears to be less prevalent in the United States than in the United Kingdom [<a href="#rid21">21</a>]. It is unclear whether this is due to the history of limited use of the drug in the United States or that the United States formulation of malathion also contains terpineol, a chemical with pediculicidal properties. In one in vitro study in Britain, fewer lice died after four hours of exposure to malathion 0.5% in isopropanol than after 30 minutes of exposure to the United States product (42 versus 96 percent) [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Side effects and patient age</strong> – <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">Malathion</a> requires longer application times than other pediculicides and is malodorous. In addition, the drug has the potential for flammability and may cause respiratory depression if ingested. The age of the child also impacts treatment selection. Safety data for use in young children vary among the pediculicides  (<a class="graphic graphic_table graphicRef105474" href="/z/d/graphic/105474.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drug cost</strong> – The high cost of some pediculicides may be prohibitive for some patients [<a href="#rid34">34,35</a>]. <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">Permethrin</a> and pyrethrins are among the least expensive topical agents [<a href="#rid35">35</a>]. United States pricing information is available in the drug information content within UpToDate.</p><p></p><p class="headingAnchor" id="H1252930"><span class="h4">Locations with low pyrethroid resistance</span><span class="headingEndMark"> — </span>Pyrethroids (pyrethrins and <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a>) are well-tolerated and inexpensive treatments that have a long history of use for pediculosis capitis. Pyrethroids are the preferred choice for initial therapy in areas where resistance to these products has not been proven [<a href="#rid13">13</a>]. This approach is consistent with guidance issued by the American Academy of Pediatrics in 2022 [<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H1253354"><span class="h5">Pyrethroids</span><span class="headingEndMark"> — </span>Made from a natural chrysanthemum extract, pyrethrins are neurotoxic to lice [<a href="#rid22">22</a>]. Pyrethrins are often combined with piperonyl butoxide, an ingredient that inhibits <a class="drug drug_general" data-topicid="9837" href="/z/d/drug information/9837.html" rel="external">pyrethrin</a> catabolism in the louse and improves efficacy. <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">Permethrin</a> is a synthetic pyrethroid:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Administration </strong>– Dry hair should be saturated with the pediculicide. The pediculicide remains on the hair for 10 minutes before rinsing off with water.</p><p></p><p class="bulletIndent1">A second treatment is indicated on day 9 or 10 [<a href="#rid13">13</a>]. One study of <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a> found lice-free rates of 83 percent on day 2, decreasing to 46 percent on day 8 before a second treatment, and then increasing to 78 percent on day 9 after the second treatment and remaining at 78 percent on day 15 [<a href="#rid36">36</a>].</p><p></p><p class="bulletIndent1">In the United Sates, lotions containing pyrethrins and piperonyl butoxide are available without a prescription, as is a 1% concentration of <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a>. Permethrin 5% is not more effective than the over-the-counter permethrin 1% preparation [<a href="#rid37">37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Precautions </strong>–<strong> </strong>Pyrethroids are generally well tolerated. However, pyrethrins may cause breathing difficulties in patients with ragweed allergy, and <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a> use is not recommended in patients who are allergic to chrysanthemums. Skin irritation is a potential side effect.</p><p></p><p class="bulletIndent1">Pyrethrins can be used for patients ≥2 years of age. <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">Permethrin</a> can be used for patients ≥2 months of age.</p><p></p><p class="headingAnchor" id="H1253243"><span class="h4">Locations with prevalent pyrethroid resistance</span><span class="headingEndMark"> — </span>In areas where resistance to pyrethroids has been documented, or in patients who have failed to respond to appropriately administered treatment with a pyrethroid, other pediculicides (such as <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a>, <a class="drug drug_general" data-topicid="16101" href="/z/d/drug information/16101.html" rel="external">spinosad</a>, and topical <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a>) are appropriate treatments. In the United States, all of these products are available only by prescription.</p><p class="headingAnchor" id="H9"><span class="h5">Malathion</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">Malathion</a> is an organophosphate cholinesterase inhibitor that exerts neurotoxic effects on lice. The agent has both pediculicidal and ovicidal properties. In comparison with pyrethroids, malathion is more expensive, has an additional side effect of flammability, and requires a longer time of application.</p><p>In the United States, <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a> is available as a product that includes terpineol, an ingredient with additional pediculicidal properties (see <a class="local">'Selection'</a> above). One in vitro study found that malathion 0.5% with terpineol was most effective at killing head lice, compared with pyrethroids and <a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">lindane</a> [<a href="#rid23">23</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Administration </strong>– <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">Malathion</a> lotion is applied to dry hair and the scalp and left in place for 8 to 12 hours before washing off with a nonmedicated shampoo [<a href="#rid38">38</a>]. The hair should be left uncovered, and heat sources should not be used to dry the hair. A single application of malathion is sufficient for most patients. If live lice are visualized seven to nine days after treatment, a second treatment is indicated.</p><p></p><p class="bulletIndent1">Some studies have suggested that shorter application times may also be effective [<a href="#rid39">39,40</a>]. In one small, investigator-blinded, randomized trial, lice were eradicated in 98 percent of patients treated with one or two 20-minute applications of <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a> with terpineol [<a href="#rid41">41</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Precautions </strong>– <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">Malathion</a> is malodorous, and its vapor is irritating to the eyes. The potential flammability of the product due to high alcohol content has also been a concern. There is a theoretical risk for respiratory depression from accidental ingestion.</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">Malathion</a> is contraindicated in children under the age of two, and studies of the safety of malathion in children under the age of six are limited. One randomized trial involving topical malathion therapy found no evidence of systemic acetylcholinesterase inhibition in children as young as two years of age [<a href="#rid42">42</a>].</p><p></p><p class="headingAnchor" id="H13"><span class="h5">Spinosad</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="16101" href="/z/d/drug information/16101.html" rel="external">Spinosad</a> is a fermentation product of the soil bacterium <em>Saccharopolyspora spinosa. </em>This drug compromises the central nervous system of lice by interfering with the nicotinic acetylcholine receptor, resulting in neuronal excitation and paralysis [<a href="#rid43">43</a>].</p><p>Two manufacturer-sponsored phase III, multicenter, randomized trials compared the efficacy and safety of <a class="drug drug_general" data-topicid="16101" href="/z/d/drug information/16101.html" rel="external">spinosad</a> 0.9% cream rinse with <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a> 1% cream rinse plus nit combing [<a href="#rid44">44</a>]. Patients who had residual live lice seven days after an initial treatment were instructed to repeat application of the same therapy. After treatment, approximately 85 percent of spinosad-treated subjects were lice-free, compared with approximately 44 percent of those treated with permethrin. Individuals treated with spinosad were also less likely to require a second application:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Administration </strong>– <a class="drug drug_general" data-topicid="16101" href="/z/d/drug information/16101.html" rel="external">Spinosad</a> is supplied as a 0.9% topical suspension. Therapy involves application to completely cover the scalp and hair. The hair should be dry prior to treatment. After application, spinosad should be left on for 10 minutes. Subsequently, the scalp and hair should be thoroughly rinsed with warm water to completely remove the product. Shampooing of the hair can be performed at any time after treatment. Treatment should be repeated if live lice remain seven days after the initial application.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Precautions </strong>– Skin irritation is a potential side effect of <a class="drug drug_general" data-topicid="16101" href="/z/d/drug information/16101.html" rel="external">spinosad</a> therapy. Spinosad is not recommended for use in children under six months of age.</p><p></p><p class="headingAnchor" id="H2579574"><span class="h5">Topical ivermectin</span><span class="headingEndMark"> — </span>Topical <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a> functions by binding to glutamate-gated chloride channels in lice, thereby inducing paralysis and death [<a href="#rid35">35</a>].</p><p>Topical <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a> therapy is supported by two randomized trials that found that a single 10-minute application was superior to a placebo lotion for the eradication of lice [<a href="#rid45">45</a>]. The primary efficacy endpoint in both trials was the number of index patients (youngest household member with at least three live lice detected on examination) who were louse-free at days 2, 8, and 15. A combined analysis of the trial results revealed that among the index patients, 131 of 138 (95 percent) treated with topical ivermectin 0.5% lotion and 46 of 147 (31 percent) treated with the placebo lotion were free of live lice on day 2. By day 15, live lice were absent in 74 and 18 percent of patients, respectively. In addition, patients in the topical ivermectin group were more likely to be free of pruritus on day 2; 67 versus 43 percent denied pruritus. Adverse events were infrequent and occurred at similar rates in both groups:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Administration </strong>– Topical <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a> 0.5% lotion is administered via a single application to dry hair. As with <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a>, a single application is sufficient. The lotion is applied to thoroughly coat the hair and scalp and is rinsed off with water after 10 minutes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Precautions </strong>– Topical <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a> generally is well tolerated. Potential adverse effects include ocular irritation, dry scalp, and a burning sensation on the skin [<a href="#rid35">35,45</a>]. The safety of ivermectin in infants under the age of six months is not established.</p><p></p><p>In 2020, the US Food and Drug Administration (FDA) approved <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a> 0.5% lotion for nonprescription use; however, commercial availability is limited [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H88875"><span class="h3">Wet combing</span><span class="headingEndMark"> — </span>Mechanical removal of lice by wet combing is an alternative treatment for patients who are too young for pediculicide treatment or who desire to avoid pediculicide therapy. The time and care required to perform wet combing and the need for multiple sessions are deterrents for some patients.</p><p>The relative effectiveness of wet combing and medical therapy is uncertain. In one study in the United Kingdom, wet combing was only half as effective as treatment with <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a> (cure in 38 versus 78 percent, respectively) [<a href="#rid47">47</a>]. Another United Kingdom study found that wet combing was much more effective than a single treatment with either malathion or <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a> (cure in 57 versus 13 percent) [<a href="#rid48">48</a>]. However, there were significant methodologic issues with this latter study, including unblinded allocation of patients, the use of an inadequate regimen of pediculicide, and different lengths of follow-up in the two arms of the study [<a href="#rid49">49</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Administration </strong>– Combing is performed with a fine-toothed comb; the hair should be wet, with an added lubricant such as hair conditioner [<a href="#rid50">50</a>]. The combing technique is the same as the combing procedure used for the diagnosis of louse infestation. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1">Combing is done until no lice are found in each session, with repeat sessions every three to four days for several weeks, continuing for two weeks after any session in which a large, adult louse is found [<a href="#rid2">2</a>]. The procedure may take 15 to 60 minutes depending on the thickness/length of hair. </p><p></p><p class="headingAnchor" id="H1256506"><span class="h2">Refractory infestations</span><span class="headingEndMark"> — </span>The most common causes of treatment failure are lack of adherence to treatment, improper application of treatment, and continued contact with other infested individuals. Resistance to specific topical treatments is a problem in some locations. (See <a class="local">'Selection'</a> above.)</p><p></p><p>If a patient fails to respond to an appropriate course of treatment with a topical pediculicide and reinfestation does not appear to be a factor, switching to an alternative topical pediculicide that has not been associated with local resistance is the typical next step. Oral <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a> is a treatment option for patients who fail topical therapy [<a href="#rid51">51,52</a>].</p><p class="headingAnchor" id="H1256517"><span class="h3">Oral ivermectin</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">Ivermectin</a> interferes with neurotransmission in arthropods and helminths, leading to paralysis and death:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Administration </strong>– Dose regimens used for pediculosis capitis have included a single 200 or 400 mcg/kg dose, usually repeated after 7 to 10 days or repeated at this point if live lice remain visible [<a href="#rid51">51-57</a>]. Because it is not clear that a 400 mcg/kg dose is superior, our preferred approach is a single 200 mcg/kg dose repeated after one week:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a randomized trial of 80 children with pediculosis capitis, treatment with <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a> (200 mcg/kg) was compared with <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a> 0.5% lotion [<a href="#rid53">53</a>]. Patients were given a single treatment of ivermectin or malathion, which was followed by a second treatment on day 8 if live lice were detected. Ivermectin and malathion were similarly effective; by day 15, 92.5 and 95 percent of patients, respectively, were cured.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a randomized, double-blind trial (n = 812), patients who failed home therapy with a pyrethroid or <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a> were treated with either malathion 0.5% lotion applied by study staff or oral <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a> (400 mcg/kg) [<a href="#rid51">51</a>]. Participants in both groups were given two treatments separated by one week. Ivermectin therapy was associated with a significantly higher rate of eradication of head lice; 95 versus 85 percent of subjects were cured of infestation. The incidence of adverse effects was similar in both groups.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Precautions </strong>– <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">Ivermectin</a> generally is well tolerated when used for pediculosis capitis; most serious adverse effects have occurred during treatment for severe microfilarial infections [<a href="#rid58">58,59</a>]. Ivermectin is not recommended for pregnant women or children weighing less than 15 kg, since safety has not been established in these populations. (See  <a class="medical medical_review" href="/z/d/html/487.html" rel="external">"Anthelminthic therapies", section on 'Ivermectin'</a>.)</p><p></p><p class="headingAnchor" id="H1254506"><span class="h2">Other therapies</span><span class="headingEndMark"> — </span>A variety of other therapies have been reported as effective for pediculosis capitis, such as <a class="drug drug_general" data-topicid="129549" href="/z/d/drug information/129549.html" rel="external">dimethicone</a>, <a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">lindane</a>, <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a>, 1,2-octanediol, a synthetic detergent cleanser, and a variety of physical methods. Routine use of many of these interventions is precluded by limited efficacy data or safety concerns.</p><p>Oily home products (eg, olive oil, butter, petroleum jelly) are sometimes used in the hopes of suffocating lice. However, lice are difficult to suffocate, and a small study of such products concluded that they are not effective [<a href="#rid40">40</a>]. Gasoline and kerosene are highly flammable and should not be used for pediculosis capitis [<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H1257041"><span class="h3">Dimethicone</span><span class="headingEndMark"> — </span>Topical <a class="drug drug_general" data-topicid="129549" href="/z/d/drug information/129549.html" rel="external">dimethicone</a> (also known as dimethicone) is widely used for pediculosis capitis in Europe. Dimethicone is a nonpesticide, silicone-based material believed to work by coating lice and disrupting their ability to manage water.</p><p>Efficacy of <a class="drug drug_general" data-topicid="129549" href="/z/d/drug information/129549.html" rel="external">dimethicone</a> is documented in multiple studies [<a href="#rid60">60-64</a>]. In a randomized, open-label trial in the United Kingdom (n = 90), a single 15-minute application of dimethicone 4% gel was superior to two 10-minute applications of <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a> 1% cream rinse (70 versus 15 percent treatment success rate) [<a href="#rid61">61</a>]. A separate assessor-blinded United Kingdom trial (n = 73) that compared two eight-hour or overnight applications of dimethicone 4% lotion with two 12-hour or overnight applications of <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a> 0.5% liquid also found dimethicone more effective [<a href="#rid62">62</a>]. A Brazilian observer-blinded randomized trial (n = 145) found two eight-hour applications of a product with 92% dimethicone superior to two 30-minute applications of a permethrin 1% lotion [<a href="#rid63">63</a>]. </p><p>A disadvantage of many <a class="drug drug_general" data-topicid="129549" href="/z/d/drug information/129549.html" rel="external">dimethicone</a> pediculicides is flammability [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H1256660"><span class="h3">Lindane</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">Lindane</a> shampoo is not recommended for the treatment for pediculosis capitis because it has been associated with rare neurologic adverse effects and widespread resistance [<a href="#rid13">13,23</a>].</p><p class="headingAnchor" id="H1256720"><span class="h4">Lindane toxicity</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">Lindane</a> is an organochlorine insecticide that inhibits neurotransmission in parasitic arthropods. Neurologic toxicity resulting in seizures and death has been reported in humans following topical lindane therapy [<a href="#rid66">66</a>]. Most of these events have occurred after prolonged or repeated application of lindane but, in rare cases, have followed a single application [<a href="#rid66">66</a>].</p><p>Although the drug has been banned in some countries and the state of California [<a href="#rid67">67</a>] and the American Academy of Pediatrics no longer recommends use of this therapy [<a href="#rid13">13</a>], <a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">lindane</a> shampoo remains available by prescription elsewhere in the United States. The US FDA has placed a black box warning on the drug labels, cautioning that lindane shampoo should only be used as a second-line treatment in patients who cannot tolerate or have failed other therapies for the treatment of scabies or lice. Lindane is contraindicated in patients with skin disorders that may lead to increased systemic absorption (eg, atopic dermatitis, psoriasis).</p><p>If used, <a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">lindane</a> should be given only as single application; <strong>retreatment should be avoided</strong>. Other measures to minimize toxicity include:</p><p class="bulletIndent1"><span class="glyph">●</span>Prescribe 1 ounce of <a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">lindane</a> shampoo to treat an average adult; no more than 2 ounces should be prescribed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">Lindane</a> shampoo prescribed for pediculosis capitis should be washed off after four minutes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Caregivers applying the drug to patients should wear gloves that are less permeable to <a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">lindane</a> (nitrile, latex, neoprene, or sheer vinyl). Natural latex gloves should not be used. Caregivers should thoroughly wash their hands after application.</p><p></p><p class="headingAnchor" id="H1256562"><span class="h3">Trimethoprim-sulfamethoxazole</span><span class="headingEndMark"> — </span>Combination therapy with topical <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a> and oral <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> may be more effective than treatment with permethrin alone. The mechanism of action of trimethoprim-sulfamethoxazole may involve the death of symbiotic bacteria in the louse gut that produce B vitamins necessary for louse survival [<a href="#rid68">68</a>].</p><p>The combination of topical <a class="drug drug_general" data-topicid="9759" href="/z/d/drug information/9759.html" rel="external">permethrin</a> (1%, applied for ten minutes with a repeat application after one week if necessary) plus oral <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> (10 mg/kg per day <a class="drug drug_general" data-topicid="10024" href="/z/d/drug information/10024.html" rel="external">trimethoprim</a> in two divided doses for ten days) was compared with either drug alone in a randomized trial of 115 children [<a href="#rid68">68</a>]. Compared with topical permethrin alone, dual therapy was associated with a higher rate of success at four weeks (93 versus 72 percent). Trimethoprim-sulfamethoxazole alone yielded a success rate of 78 percent. Although rare, potential adverse effects of trimethoprim-sulfamethoxazole include Stevens-Johnson syndrome, neutropenia, hemolysis, and renal impairment. The authors of the study concluded that dual therapy should be reserved for resistant cases.</p><p class="headingAnchor" id="H1256981"><span class="h3">1,2-octanediol</span><span class="headingEndMark"> — </span>Data from randomized trials suggest that topical preparations containing 1,2-octanediol, an agent that may disrupt cuticular lipids on head lice and their eggs, are beneficial for the treatment and prevention of pediculosis capitis [<a href="#rid69">69,70</a>]. Topical 1,2-octanediol is not commercially available in the United States.</p><p class="headingAnchor" id="H419763673"><span class="h3">Synthetic detergent cleanser</span><span class="headingEndMark"> — </span>Two prospective studies of a synthetic detergent cleanser applied to the head and then dried, with a goal of suffocating lice, reported a 96 percent cure rate [<a href="#rid71">71,72</a>]. The studies had significant flaws, including lack of a control group, lack of blinding, and potentially inappropriate diagnostic criteria [<a href="#rid73">73</a>]. Further studies are needed before this approach can be recommended.</p><p class="headingAnchor" id="H419763660"><span class="h3">Physical methods</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hair removal </strong>–<strong> </strong>Shaving hair is anecdotally reported as a method of eradicating head louse infestation [<a href="#rid74">74</a>]. However, studies evaluating this method of treatment have not been performed, and the procedure may be psychologically distressing for some patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electric comb </strong>– A comb that uses an electric current generated by an AA battery to electrocute lice is marketed for the treatment of head lice. Although there are anecdotal reports of successful treatment with the device [<a href="#rid75">75</a>], there are no published clinical trials.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Heated air </strong>– An unblinded study reported louse eradication with high-volume heated air blown at the scalp for 30 minutes [<a href="#rid76">76</a>]. Few patients overall received the high-volume heated air treatments, and patients younger than age six were excluded. While awaiting the results of larger controlled trials that compare methods of delivering heat and assess cure, safety, training, and costs, such treatment cannot be recommended.</p><p></p><p class="headingAnchor" id="H25"><span class="h1">RETURN TO SCHOOL</span><span class="headingEndMark"> — </span>Children should <strong>not</strong> be excluded from school based upon the presence of live lice or nits [<a href="#rid77">77</a>]. Lice often are present for weeks prior to detection. Furthermore, the majority of children with nits do not develop active infestation [<a href="#rid17">17</a>]. Affected children should avoid direct head contact with other individuals and should be treated promptly with a topical pediculicide or wet-combing session. <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fparasites%2Flice%2Fhead%2Fschools.html&amp;token=h4eUJmqL9C3uQGltzhHclS8VQAwGswM4UUljpjDrZG%2BkmCVuC1j5sy5tMILIA2vrwKqyskttLoKkjkUfEF%2FaRg%3D%3D&amp;TOPIC_ID=4035" target="_blank">The Centers for Disease Control</a> provides a brief summary of the recommended approach to children with lice in schools.</p><p>Control of outbreaks in schools may be facilitated by examination of teachers and pupils who may have had close head-to-head contact with an affected child and by assigning students individual wall hooks or lockers for storing caps and coats [<a href="#rid39">39</a>]. Education programs designed to increase knowledge about pediculosis capitis and methods to prevent infestation in a community may also be beneficial [<a href="#rid78">78</a>].</p><p class="headingAnchor" id="H26"><span class="h1">HOUSEHOLD RECOMMENDATIONS</span><span class="headingEndMark"> — </span>Household members should be examined and treated if infested (live lice or nits within 1 cm of the scalp detected); bedmates should be treated prophylactically [<a href="#rid13">13</a>].</p><p>Louse survival off the scalp beyond 48 hours is unlikely [<a href="#rid13">13</a>]. It is reasonable to recommend washing hair care items, clothing, and linen used by the infested person during the two days prior to therapy in hot water and drying the items on a high-heat dryer cycle [<a href="#rid13">13</a>]. Temperatures should reach at least 130°F. Items that cannot be washed may be dry-cleaned or stored in a sealed plastic bag for two weeks [<a href="#rid1">1,13</a>]. Vacuuming of furniture and carpeting on which the infested person sat or lay down has also been suggested; of note, the risk of transmission from these sites is low [<a href="#rid6">6,13</a>]. Spraying the home with a pediculicide is not recommended.</p><p class="headingAnchor" id="H1684087444"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/117632.html" rel="external">"Society guideline links: Pediculosis"</a>.)</p><p class="headingAnchor" id="H27"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15487.html" rel="external">"Patient education: Lice (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/2732.html" rel="external">"Patient education: Head lice (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/2733.html" rel="external">"Patient education: Pubic lice (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H28"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview </strong>–<strong> </strong>Pediculosis capitis (head lice) is a scalp infestation that most frequently occurs in children. Affected individuals may be asymptomatic or may complain of scalp or neck pruritus. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>–<strong> </strong>Pediculosis capitis is diagnosed by visual examination. In cases of active infestation, louse eggs (nits) are found on hair shafts, and crawling nymphs and adult lice are present. Wet combing is a useful technique for locating adult lice or nymphs. The presence of nits alone does <strong>not</strong> confirm active infestation. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment </strong>–<strong> </strong>Several topical pediculicides are available for the treatment of pediculosis capitis:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Selection </strong>–<strong> </strong>Resistance to topical agents that kill lice via neurotoxic mechanisms has been increasingly reported and varies geographically. The selection of a topical agent should be based upon local resistance patterns and consideration of adverse effects and patient age. Treatment with <a class="drug drug_general" data-topicid="9562" href="/z/d/drug information/9562.html" rel="external">lindane</a> is not recommended due to the potential for neurologic side effects and the drug's relatively low efficacy. (See <a class="local">'Topical pediculicides'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Preferred first-line treatments </strong>–<strong> </strong>First-line treatment options for pediculosis capitis include pyrethroids, <a class="drug drug_general" data-topicid="9584" href="/z/d/drug information/9584.html" rel="external">malathion</a>, <a class="drug drug_general" data-topicid="16101" href="/z/d/drug information/16101.html" rel="external">spinosad</a>, and topical <a class="drug drug_general" data-topicid="8641" href="/z/d/drug information/8641.html" rel="external">ivermectin</a>  (<a class="graphic graphic_table graphicRef105474" href="/z/d/graphic/105474.html" rel="external">table 1</a>). The safety, low cost, and easy availability of pyrethroids have led to the widespread use of these drugs as initial agents. In areas in which pyrethroid resistance is not likely, we suggest use of a pyrethroid as first-line therapy (<a class="grade" href="https:///uptodate/show/grade_4" rel="external">Grade 2A</a>). (See <a class="local">'Topical pediculicides'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment failure </strong>–<strong> </strong>Treatment failure may occur secondary to lack of adherence to the treatment regimen or reinfestation. Clinicians should consider these factors, in addition to the possibility of resistance, when evaluating patients with an apparent lack of response to therapy. (See <a class="local">'Refractory infestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>School attendance and management of close contacts </strong>–<strong> </strong>Children with pediculosis capitis do not need to be excluded from school. Household members and close contacts should be examined for infestation. Individuals who share bedding with the affected person should be treated prophylactically. (See <a class="local">'Return to school'</a> above and <a class="local">'Household recommendations'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Ko CJ, Elston DM. Pediculosis. J Am Acad Dermatol 2004; 50:1.</a></li><li><a class="nounderline abstract_t">Roberts RJ. Clinical practice. Head lice. N Engl J Med 2002; 346:1645.</a></li><li><a class="nounderline abstract_t">Falagas ME, Matthaiou DK, Rafailidis PI, et al. Worldwide prevalence of head lice. Emerg Infect Dis 2008; 14:1493.</a></li><li><a class="nounderline abstract_t">Chunge RN, Scott FE, Underwood JE, Zavarella KJ. A pilot study to investigate transmission of headlice. Can J Public Health 1991; 82:207.</a></li><li><a class="nounderline abstract_t">Frankowski BL, Bocchini JA Jr, Council on School Health and Committee on Infectious Diseases. Head lice. Pediatrics 2010; 126:392.</a></li><li class="breakAll">US Centers for Disease Control and Prevention. Head Lice: Prevention and Control. https://www.cdc.gov/parasites/lice/head/prevent.html (Accessed on October 03, 2022).</li><li><a class="nounderline abstract_t">Burkhart CN, Burkhart CG. Fomite transmission in head lice. J Am Acad Dermatol 2007; 56:1044.</a></li><li><a class="nounderline abstract_t">Canyon DV, Speare R. Indirect transmission of head lice via inanimate objects. Open Dermatology Journal 2010; 4:72.</a></li><li><a class="nounderline abstract_t">Takano-Lee M, Edman JD, Mullens BA, Clark JM. Transmission potential of the human head louse, Pediculus capitis (Anoplura: Pediculidae). Int J Dermatol 2005; 44:811.</a></li><li><a class="nounderline abstract_t">Speare R, Cahill C, Thomas G. Head lice on pillows, and strategies to make a small risk even less. Int J Dermatol 2003; 42:626.</a></li><li><a class="nounderline abstract_t">Speare R, Buettner PG. Hard data needed on head lice transmission. Int J Dermatol 2000; 39:877.</a></li><li><a class="nounderline abstract_t">Speare R, Thomas G, Cahill C. Head lice are not found on floors in primary school classrooms. Aust N Z J Public Health 2002; 26:208.</a></li><li><a class="nounderline abstract_t">Nolt D, Moore S, Yan AC, et al. Head Lice. Pediatrics 2022; 150.</a></li><li><a class="nounderline abstract_t">Jahnke C, Bauer E, Hengge UR, Feldmeier H. Accuracy of diagnosis of pediculosis capitis: visual inspection vs wet combing. Arch Dermatol 2009; 145:309.</a></li><li><a class="nounderline abstract_t">Mumcuoglu KY, Friger M, Ioffe-Uspensky I, et al. Louse comb versus direct visual examination for the diagnosis of head louse infestations. Pediatr Dermatol 2001; 18:9.</a></li><li><a class="nounderline abstract_t">Zalaudek I, Argenziano G. Images in clinical medicine. Dermoscopy of nits and pseudonits. N Engl J Med 2012; 367:1741.</a></li><li><a class="nounderline abstract_t">Williams LK, Reichert A, MacKenzie WR, et al. Lice, nits, and school policy. Pediatrics 2001; 107:1011.</a></li><li><a class="nounderline abstract_t">Keipert JA. Hair casts. Review and suggestion regarding nomenclature. Arch Dermatol 1986; 122:927.</a></li><li><a class="nounderline abstract_t">França K, Villa RT, Silva IR, et al. Hair casts or pseudonits. Int J Trichology 2011; 3:121.</a></li><li><a class="nounderline abstract_t">Bonifaz A, Gómez-Daza F, Paredes V, Ponce RM. Tinea versicolor, tinea nigra, white piedra, and black piedra. Clin Dermatol 2010; 28:140.</a></li><li><a class="nounderline abstract_t">Lebwohl M, Clark L, Levitt J. Therapy for head lice based on life cycle, resistance, and safety considerations. Pediatrics 2007; 119:965.</a></li><li><a class="nounderline abstract_t">Frankowski BL, Weiner LB, Committee on School Health the Committee on Infectious Diseases. American Academy of Pediatrics. Head lice. Pediatrics 2002; 110:638.</a></li><li><a class="nounderline abstract_t">Meinking TL, Serrano L, Hard B, et al. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol 2002; 138:220.</a></li><li><a class="nounderline abstract_t">Yoon KS, Gao JR, Lee SH, et al. Permethrin-resistant human head lice, Pediculus capitis, and their treatment. Arch Dermatol 2003; 139:994.</a></li><li><a class="nounderline abstract_t">Hunter JA, Barker SC. Susceptibility of head lice (Pediculus humanus capitis) to pediculicides in Australia. Parasitol Res 2003; 90:476.</a></li><li><a class="nounderline abstract_t">Kasai S, Ishii N, Natsuaki M, et al. Prevalence of kdr-like mutations associated with pyrethroid resistance in human head louse populations in Japan. J Med Entomol 2009; 46:77.</a></li><li><a class="nounderline abstract_t">Durand R, Millard B, Bouges-Michel C, et al. Detection of pyrethroid resistance gene in head lice in schoolchildren from Bobigny, France. J Med Entomol 2007; 44:796.</a></li><li><a class="nounderline abstract_t">Downs AM, Stafford KA, Hunt LP, et al. Widespread insecticide resistance in head lice to the over-the-counter pediculocides in England, and the emergence of carbaryl resistance. Br J Dermatol 2002; 146:88.</a></li><li><a class="nounderline abstract_t">Pollack RJ, Kiszewski A, Armstrong P, et al. Differential permethrin susceptibility of head lice sampled in the United States and Borneo. Arch Pediatr Adolesc Med 1999; 153:969.</a></li><li><a class="nounderline abstract_t">Soderlund DM. Pyrethroids, knockdown resistance and sodium channels. Pest Manag Sci 2008; 64:610.</a></li><li><a class="nounderline abstract_t">Gellatly KJ, Krim S, Palenchar DJ, et al. Expansion of the Knockdown Resistance Frequency Map for Human Head Lice (Phthiraptera: Pediculidae) in the United States Using Quantitative Sequencing. J Med Entomol 2016; 53:653.</a></li><li><a class="nounderline abstract_t">Bialek R, Zelck UE, Fölster-Holst R. Permethrin treatment of head lice with knockdown resistance-like gene. N Engl J Med 2011; 364:386.</a></li><li><a class="nounderline abstract_t">Downs AM, Narayan S, Stafford KA, Coles GC. Effectiveness of ovide against malathion-resistant head lice. Arch Dermatol 2005; 141:1318.</a></li><li><a class="nounderline abstract_t">Spinosad (Natroba) topical suspension for head lice. Med Lett Drugs Ther 2011; 53:50.</a></li><li><a class="nounderline abstract_t">Ivermectin (Sklice) topical lotion for head lice. Med Lett Drugs Ther 2012; 54:61.</a></li><li><a class="nounderline abstract_t">Meinking TL, Clineschmidt CM, Chen C, et al. An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice. J Pediatr 2002; 141:665.</a></li><li><a class="nounderline abstract_t">Downs AM, Stafford KA, Coles GC. Head lice: prevalence in schoolchildren and insecticide resistance. Parasitol Today 1999; 15:1.</a></li><li><a class="nounderline abstract_t">Malathion for treatment of head lice. Med Lett Drugs Ther 1999; 41:73.</a></li><li><a class="nounderline abstract_t">Frankowski BL. American Academy of Pediatrics guidelines for the prevention and treatment of head lice infestation. Am J Manag Care 2004; 10:S269.</a></li><li><a class="nounderline abstract_t">Takano-Lee M, Edman JD, Mullens BA, Clark JM. Home remedies to control head lice: assessment of home remedies to control the human head louse, Pediculus humanus capitis (Anoplura: Pediculidae). J Pediatr Nurs 2004; 19:393.</a></li><li><a class="nounderline abstract_t">Meinking TL, Vicaria M, Eyerdam DH, et al. Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice. Pediatr Dermatol 2004; 21:670.</a></li><li><a class="nounderline abstract_t">Meinking TL, Vicaria M, Eyerdam DH, et al. A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Crème Rinse (1% permethrin) used as labeled, for the treatment of head lice. Pediatr Dermatol 2007; 24:405.</a></li><li><a class="nounderline abstract_t">McCormack PL. Spinosad: in pediculosis capitis. Am J Clin Dermatol 2011; 12:349.</a></li><li><a class="nounderline abstract_t">Stough D, Shellabarger S, Quiring J, Gabrielsen AA Jr. Efficacy and safety of spinosad and permethrin creme rinses for pediculosis capitis (head lice). Pediatrics 2009; 124:e389.</a></li><li><a class="nounderline abstract_t">Pariser DM, Meinking TL, Bell M, Ryan WG. Topical 0.5% ivermectin lotion for treatment of head lice. N Engl J Med 2012; 367:1687.</a></li><li class="breakAll">US Food and Drug Administration. FDA Approves Lotion for Nonprescription Use to Treat Head Lice. https://www.fda.gov/news-events/press-announcements/fda-approves-lotion-nonprescription-use-treat-head-lice (Accessed on December 10, 2020).</li><li><a class="nounderline abstract_t">Roberts RJ, Casey D, Morgan DA, Petrovic M. Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised controlled trial. Lancet 2000; 356:540.</a></li><li><a class="nounderline abstract_t">Hill N, Moor G, Cameron MM, et al. Single blind, randomised, comparative study of the Bug Buster kit and over the counter pediculicide treatments against head lice in the United Kingdom. BMJ 2005; 331:384.</a></li><li><a class="nounderline abstract_t">Dawes M. Combing and combating head lice. BMJ 2005; 331:362.</a></li><li><a class="nounderline abstract_t">Lapeere H, Brochez L, Verhaeghe E, et al. Efficacy of products to remove eggs of Pediculus humanus capitis (Phthiraptera: Pediculidae) from the human hair. J Med Entomol 2014; 51:400.</a></li><li><a class="nounderline abstract_t">Chosidow O, Giraudeau B, Cottrell J, et al. Oral ivermectin versus malathion lotion for difficult-to-treat head lice. N Engl J Med 2010; 362:896.</a></li><li><a class="nounderline abstract_t">Ameen M, Arenas R, Villanueva-Reyes J, et al. Oral ivermectin for treatment of pediculosis capitis. Pediatr Infect Dis J 2010; 29:991.</a></li><li><a class="nounderline abstract_t">Nofal A. Oral ivermectin for head lice: a comparison with 0.5 % topical malathion lotion. J Dtsch Dermatol Ges 2010; 8:985.</a></li><li><a class="nounderline abstract_t">Currie MJ, Reynolds GJ, Glasgow NJ, Bowden FJ. A pilot study of the use of oral ivermectin to treat head lice in primary school students in Australia. Pediatr Dermatol 2010; 27:595.</a></li><li><a class="nounderline abstract_t">Pilger D, Heukelbach J, Khakban A, et al. Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer-blinded controlled trial. Bull World Health Organ 2010; 88:90.</a></li><li><a class="nounderline abstract_t">Glaziou P, Nyguyen LN, Moulia-Pelat JP, et al. Efficacy of ivermectin for the treatment of head lice (Pediculosis capitis). Trop Med Parasitol 1994; 45:253.</a></li><li><a class="nounderline abstract_t">Burkhart CG, Burkhart CN. Head lice therapies revisited. Dermatol Online J 2006; 12:3.</a></li><li><a class="nounderline abstract_t">Twum-Danso NA. Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases. Filaria J 2003; 2 Suppl 1:S3.</a></li><li><a class="nounderline abstract_t">Gardon J, Gardon-Wendel N, Demanga-Ngangue, et al. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 1997; 350:18.</a></li><li><a class="nounderline abstract_t">Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation with 4% dimeticone lotion: randomised controlled equivalence trial. BMJ 2005; 330:1423.</a></li><li><a class="nounderline abstract_t">Burgess IF, Brunton ER, Burgess NA. Single application of 4% dimeticone liquid gel versus two applications of 1% permethrin creme rinse for treatment of head louse infestation: a randomised controlled trial. BMC Dermatol 2013; 13:5.</a></li><li><a class="nounderline abstract_t">Burgess IF, Lee PN, Matlock G. Randomised, controlled, assessor blind trial comparing 4% dimeticone lotion with 0.5% malathion liquid for head louse infestation. PLoS One 2007; 2:e1127.</a></li><li><a class="nounderline abstract_t">Heukelbach J, Pilger D, Oliveira FA, et al. A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial. BMC Infect Dis 2008; 8:115.</a></li><li><a class="nounderline abstract_t">Ihde ES, Boscamp JR, Loh JM, Rosen L. Safety and efficacy of a 100% dimethicone pediculocide in school-age children. BMC Pediatr 2015; 15:70.</a></li><li><a class="nounderline abstract_t">Dörge DD, Kuhn T, Klimpel S. Flammability testing of 22 conventional European pediculicides. Parasitol Res 2017; 116:1189.</a></li><li class="breakAll">www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm110845.htm (Accessed on October 09, 2009).</li><li><a class="nounderline abstract_t">Humphreys EH, Janssen S, Heil A, et al. Outcomes of the California ban on pharmaceutical lindane: clinical and ecologic impacts. Environ Health Perspect 2008; 116:297.</a></li><li><a class="nounderline abstract_t">Hipolito RB, Mallorca FG, Zuniga-Macaraig ZO, et al. Head lice infestation: single drug versus combination therapy with one percent permethrin and trimethoprim/sulfamethoxazole. Pediatrics 2001; 107:E30.</a></li><li><a class="nounderline abstract_t">Burgess IF, Brunton ER, French R, et al. Prevention of head louse infestation: a randomised, double-blind, cross-over study of a novel concept product, 1% 1,2-octanediol spray versus placebo. BMJ Open 2014; 4:e004634.</a></li><li><a class="nounderline abstract_t">Burgess IF, Lee PN, Kay K, et al. 1,2-Octanediol, a novel surfactant, for treating head louse infestation: identification of activity, formulation, and randomised, controlled trials. PLoS One 2012; 7:e35419.</a></li><li><a class="nounderline abstract_t">Pearlman DL. A simple treatment for head lice: dry-on, suffocation-based pediculicide. Pediatrics 2004; 114:e275.</a></li><li><a class="nounderline abstract_t">Pearlman D. Cetaphil cleanser (Nuvo lotion) cures head lice. Pediatrics 2005; 116:1612.</a></li><li><a class="nounderline abstract_t">Roberts RJ, Burgess IF. New head-lice treatments: hope or hype? Lancet 2005; 365:8.</a></li><li><a class="nounderline abstract_t">Lwegaba A. Shaving can be safer head lice treatment than insecticides. BMJ 2005; 330:1510.</a></li><li><a class="nounderline abstract_t">Resnik KS. A non-chemical therapeutic modality for head lice. J Am Acad Dermatol 2005; 52:374.</a></li><li><a class="nounderline abstract_t">Goates BM, Atkin JS, Wilding KG, et al. An effective nonchemical treatment for head lice: a lot of hot air. Pediatrics 2006; 118:1962.</a></li><li><a class="nounderline abstract_t">Devore CD, Schutze GE, Council on School Health and Committee on Infectious Diseases, American Academy of Pediatrics. Head lice. Pediatrics 2015; 135:e1355.</a></li><li><a class="nounderline abstract_t">Yingklang M, Sengthong C, Haonon O, et al. Effect of a health education program on reduction of pediculosis in school girls at Amphoe Muang, Khon Kaen Province, Thailand. PLoS One 2018; 13:e0198599.</a></li></ol></div><div id="topicVersionRevision">Topic 4035 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14699358" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Pediculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12023998" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Clinical practice. Head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18760032" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Worldwide prevalence of head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1884317" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : A pilot study to investigate transmission of headlice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20660553" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20660553" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17187895" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Fomite transmission in head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Indirect transmission of head lice via inanimate objects</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16207180" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Transmission potential of the human head louse, Pediculus capitis (Anoplura: Pediculidae).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12890107" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Head lice on pillows, and strategies to make a small risk even less.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11123459" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hard data needed on head lice transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12141614" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Head lice are not found on floors in primary school classrooms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36156158" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Head Lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19289764" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Accuracy of diagnosis of pediculosis capitis: visual inspection vs wet combing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11207962" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Louse comb versus direct visual examination for the diagnosis of head louse infestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23113485" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Images in clinical medicine. Dermoscopy of nits and pseudonits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11331679" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Lice, nits, and school policy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2427036" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hair casts. Review and suggestion regarding nomenclature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22223977" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Hair casts or pseudonits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20347655" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Tinea versicolor, tinea nigra, white piedra, and black piedra.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17473098" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Therapy for head lice based on life cycle, resistance, and safety considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12205271" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11843643" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12925385" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Permethrin-resistant human head lice, Pediculus capitis, and their treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12827503" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Susceptibility of head lice (Pediculus humanus capitis) to pediculicides in Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19198520" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Prevalence of kdr-like mutations associated with pyrethroid resistance in human head louse populations in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17915510" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Detection of pyrethroid resistance gene in head lice in schoolchildren from Bobigny, France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11841371" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Widespread insecticide resistance in head lice to the over-the-counter pediculocides in England, and the emergence of carbaryl resistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10482215" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Differential permethrin susceptibility of head lice sampled in the United States and Borneo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18383430" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pyrethroids, knockdown resistance and sodium channels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27032417" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Expansion of the Knockdown Resistance Frequency Map for Human Head Lice (Phthiraptera: Pediculidae) in the United States Using Quantitative Sequencing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21268748" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Permethrin treatment of head lice with knockdown resistance-like gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16230576" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Effectiveness of ovide against malathion-resistant head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21701441" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Spinosad (Natroba) topical suspension for head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22869290" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Ivermectin (Sklice) topical lotion for head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12410195" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10234166" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Head lice: prevalence in schoolchildren and insecticide resistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10603987" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Malathion for treatment of head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15515631" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : American Academy of Pediatrics guidelines for the prevention and treatment of head lice infestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15637580" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Home remedies to control head lice: assessment of home remedies to control the human head louse, Pediculus humanus capitis (Anoplura: Pediculidae).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15575855" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17845167" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Crème Rinse (1% permethrin) used as labeled, for the treatment of head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21834600" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Spinosad: in pediculosis capitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19706558" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Efficacy and safety of spinosad and permethrin creme rinses for pediculosis capitis (head lice).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23113480" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Topical 0.5% ivermectin lotion for treatment of head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23113480" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Topical 0.5% ivermectin lotion for treatment of head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10950230" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16085658" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Single blind, randomised, comparative study of the Bug Buster kit and over the counter pediculicide treatments against head lice in the United Kingdom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16096290" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Combing and combating head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24724290" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Efficacy of products to remove eggs of Pediculus humanus capitis (Phthiraptera: Pediculidae) from the human hair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20220184" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Oral ivermectin versus malathion lotion for difficult-to-treat head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21046698" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Oral ivermectin for treatment of pediculosis capitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20718901" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Oral ivermectin for head lice: a comparison with 0.5 % topical malathion lotion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21138467" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A pilot study of the use of oral ivermectin to treat head lice in primary school students in Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20428365" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer-blinded controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7899799" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Efficacy of ivermectin for the treatment of head lice (Pediculosis capitis).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17083883" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Head lice therapies revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14975060" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9217715" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15951310" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Treatment of head louse infestation with 4% dimeticone lotion: randomised controlled equivalence trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23548062" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Single application of 4% dimeticone liquid gel versus two applications of 1% permethrin creme rinse for treatment of head louse infestation: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17987114" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Randomised, controlled, assessor blind trial comparing 4% dimeticone lotion with 0.5% malathion liquid for head louse infestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18783606" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26092045" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Safety and efficacy of a 100% dimethicone pediculocide in school-age children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28155106" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Flammability testing of 22 conventional European pediculicides.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28155106" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Flammability testing of 22 conventional European pediculicides.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18335094" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Outcomes of the California ban on pharmaceutical lindane: clinical and ecologic impacts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11230611" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Head lice infestation: single drug versus combination therapy with one percent permethrin and trimethoprim/sulfamethoxazole.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24879825" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Prevention of head louse infestation: a randomised, double-blind, cross-over study of a novel concept product, 1% 1,2-octanediol spray versus placebo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22523593" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : 1,2-Octanediol, a novel surfactant, for treating head louse infestation: identification of activity, formulation, and randomised, controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15342886" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A simple treatment for head lice: dry-on, suffocation-based pediculicide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16322200" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Cetaphil cleanser (Nuvo lotion) cures head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15639662" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : New head-lice treatments: hope or hype?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15976435" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Shaving can be safer head lice treatment than insecticides.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15692498" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : A non-chemical therapeutic modality for head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17079567" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : An effective nonchemical treatment for head lice: a lot of hot air.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25917986" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Head lice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29889851" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Effect of a health education program on reduction of pediculosis in school girls at Amphoe Muang, Khon Kaen Province, Thailand.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
